| Autor: |
Alkhateeb S; Department of Surgery, Division of Urology, King Abdulaziz Medical City, King Saud Bin Abdulaziz University for Health Sciences, Riyadh, Saudi Arabia., Al-Mansour M; Department of Oncology, King Abdulaziz Medical City, King Saud Bin Abdulaziz University for Health Sciences, Jeddah, Saudi Arabia., Alotaibi M; Department of Urology, King Faisal Specialist Hospital and Research Center, Riyadh, Saudi Arabia., Saadeddin A; Department of Oncology, King Abdulaziz Medical City, Riyadh, Saudi Arabia., Abusamra A; Department of Surgery, Urology Section, King Khalid Hospital, King Abdulaziz Medical City, Ministry of National Guard Health Affairs, Jeddah, Saudi Arabia., Rabah D; Department of Surgery, College of Medicine and Uro-Oncology Research Chair, King Saud University, Riyadh, Saudi Arabia., Murshid E; Department of Oncology, Oncology Center, Prince Sultan Medical Military City, Jeddah, Saudi Arabia., Alsharm A; Department of Medical Oncology, Comprehensive Cancer Center, King Fahad Medical City, Riyadh, Saudi Arabia., Ahmad I; Department of Oncology, King Faisal Specialist Hospital and Research Center, Riyadh, Saudi Arabia., Kushi H; Department of Radiation Oncology, Princess Norah Oncology Center, King Abdulaziz Medical City, Jeddah, Saudi Arabia., Alghamdi A; Department of Urology, Prince Sultan Medical Military Center, Jeddah, Saudi Arabia., Alghamdi K; Department of Surgery, Division of Urology, Security Forces Hospital, Riyadh, Saudi Arabia., Bazarbashi S; Department of Oncology, Section of Medical Oncology, Oncology Center, King Faisal Specialist Hospital and Research Center, Riyadh, Saudi Arabia. |
| Abstrakt: |
This is an update to the previously published Saudi guidelines for the evaluation, medical, and surgical management of patients diagnosed with urothelial cell carcinoma of the urinary bladder. It is categorized according to the stage of the disease using the tumor node metastasis staging system 7(th) edition. The guidelines are presented with supporting evidence level, they are based on comprehensive literature review, several internationally recognized guidelines, and the collective expertise of the guidelines committee members (authors) who were selected by the Saudi Oncology Society and Saudi Urological Association. Considerations to the local availability of drugs, technology, and expertise have been regarded. These guidelines should serve as a roadmap for the urologists, oncologists, general physicians, support groups, and health care policy makers in the management of patients diagnosed with urothelial cell carcinoma of the urinary bladder. |
